Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy

Audrey M Sigmund,* Kieran D Sahasrabudhe,* Bhavana Bhatnagar Division of Hematology, Department of Internal Medicine, The Ohio State University and the Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA*These authors contributed equally to this workCorrespondence: Bhavana Bha...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sigmund AM, Sahasrabudhe KD, Bhatnagar B
Format: article
Langue:EN
Publié: Dove Medical Press 2020
Sujets:
mrd
Accès en ligne:https://doaj.org/article/b11495eba1d74f478741d26b3469e17b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!